One of the primary limitations of stem cell treatment and the subject of ongoing research is the challenge of directing stem cells to their necessary destination in the body which has been a subject of ongoing research. Prior studies have discovered that stem cells are drawn to inflammation in the body, however, using this as a therapeutic lure still poses risks. Thus, researchers continue their search for tools that would aid stem cells in their migration and conversion into specific types of cells necessary for optimal treatment. The ability to do so would have a wide range of implications for regenerative medicine as well as the treatment of disorders in which inflammatory signals fade over time, such as chronic spinal cord injury, stroke, or conditions in which the role of inflammation remains unknown. Continue reading
Currently, gene therapy, biomedical engineering, and stem cell therapies are among some of the most common and widely studied regenerative medicine techniques. Unfortunately, most of the strategies available today lack key characteristics – such as selectivity and reversibility – and researchers continue to investigate a range of promising alternatives in their quest to delay the aging process and mitigate the body’s susceptibility to disease. A new discovery in the field of regenerative medicine exhibits potential to spark advances in the field of tissue engineering; novel research from the Istituto Italiano di Tecnologia (IIT) in Milan has revealed the benefit of using light to facilitate the formation of new blood vessels in a new technique called “optoceutics.”
A growing body of research demonstrates significant discoveries and advancements in knowledge into potential biomedical strategies for reversing the aging process. Today, researchers continue to study animal and human abilities to regenerate cells, aiming to diminish cognitive decline, immune system weakening, and other adverse effects of the biological aging process. Meanwhile, healthcare and biotech companies race to “find the key” to reversing the aging process, bringing the market valuation of anti-aging medicine to a projected $610 billion by 2025 from current estimates of $110 billion. Investors are pouring millions into start-up companies that focus on anti-aging and regenerative medical research, in hopes of being the first organization to make a breakthrough – bringing a successful solution to aging to the public.